-
Featured
Pilot Study: DASH Diet Reduces Serum Urate in Patients with Gout
Hyon K. Choi, MD, of the Division of Rheumatology, Allergy and Immunology, and colleagues report preliminary evidence that a dietitian-directed, DASH-patterned behavioral intervention lowers serum urate in gout patients not on urate-lowering drugs.
-
Study Positions SGLT2 Inhibitors as Gout Treatment
A Massachusetts General Hospital research team has found that SGLT2 inhibitor therapy reduces gout flares and lowers the risk of myocardial infarction in patients with diabetes.
-
Allopurinol Treatment-to-Target Does Not Increase Mortality Risk in Patients With Comorbid Gout, CKD
Yuqing Zhang, DSc, Hyon K. Choi, MD, and colleagues found that allopurinol use does not increase the five-year risk of death in patients with gout and concurrent chronic kidney disease, either overall or when analyses were limited to patients who achieved the target serum urate level or required dose escalation.
-
Review: Cardiometabolic–Renal Comorbidities in Gout
Hyon K. Choi, MD, Chio Yokose, MD, MS, and Natalie McCormick, PhD, of the Division of Rheumatology, Allergy and Immunology, suggest pharmacologic agents that can both lower urate levels in patients with gout and treat common cardiometabolic-renal comorbidities of the disease.
-
Clinical Epidemiology Program Advances Rheumatology Care
Massachusetts General Hospital's Clinical Epidemiology Program utilizes multidisciplinary collaborations, big data and omics sciences to advance rheumatology and COVID-19 care.
-
Rheumatology Ultrasound Improves Diagnosis of Inflammation
Massachusetts General Hospital's Rheumatology Musculoskeletal Ultrasound Program improves early diagnosis and treatment of psoriatic arthritis and other inflammatory diseases.
Gout Contributors
-
Hyon Choi, MD, DrPH
Director, Clinical Epidemiology and Health Outcomes Research, Division of Rheumatology, Allergy and Immunology, Clinical Rheumatologist, Department of Medicine, Massachusetts General Hospital, Professor of Medicine, Harvard Medical School
Recent Article
Study Positions SGLT2 Inhibitors as Gout Treatment
-
Minna J. Kohler, MD, RhMSUS
Director, Rheumatology Musculoskeletal Ultrasound Program
Recent Article
Rheumatology Ultrasound Improves Diagnosis of Inflammation
Rheumatology, Allergy and Immunology
The Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital provides leading-edge treatment and transformative care to patients with rheumatic disease and autoimmune conditions.